Cognition Therapeutics (CGTX) Insider Trading & Ownership $0.67 +0.08 (+13.93%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$0.68 +0.01 (+1.44%) As of 08/1/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cognition Therapeutics (NASDAQ:CGTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage14.40%Number OfInsiders Buying(Last 3 Years)3Amount OfInsider Buying(Last 3 Years)$67.08KNumber OfInsiders Selling(Last 3 Years)0 Get CGTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Cognition Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CGTX Insider Buying and Selling by Quarter Cognition Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/14/2024Lisa RicciardiCEOBuy5,700$1.75$9,975.00 11/29/2022Ellen B RichstoneDirectorBuy10,000$2.65$26,500.00 11/15/2022Lisa RicciardiCEOBuy12,000$1.30$15,600.00 11/15/2022Peggy WallaceDirectorBuy12,500$1.20$15,000.00 (Data available from 1/1/2013 forward) CGTX Insider Trading Activity - Frequently Asked Questions Who is on Cognition Therapeutics' Insider Roster? The list of insiders at Cognition Therapeutics includes Ellen B Richstone, Lisa Ricciardi, and Peggy Wallace. Learn more on insiders at CGTX. What percentage of Cognition Therapeutics stock is owned by insiders? 14.40% of Cognition Therapeutics stock is owned by insiders. Learn more on CGTX's insider holdings. Which Cognition Therapeutics insiders have been buying company stock? The following insider purchased CGTX shares in the last 24 months: Lisa Ricciardi ($9,975.00). How much insider buying is happening at Cognition Therapeutics? Insiders have purchased a total of 5,700 CGTX shares in the last 24 months for a total of $9,975.00 bought. Cognition Therapeutics Key ExecutivesMs. Lisa Ricciardi (Age 64)CEO, President & Director Compensation: $854.15kMr. John Brendan Doyle (Age 47)Chief Financial Officer Compensation: $414.88kDr. Anthony O. Caggiano M.D. (Age 54)Ph.D., Chief Medical Officer and Head of R&D Compensation: $616.27kDr. Steven A. Weissman Ph.D.VP & Head of CMC More Insider Trading Tools from MarketBeat Related Companies Semper Paratus Acquisition Insider Buying CytomX Therapeutics Insider Buying enGene Insider Buying Kyverna Therapeutics Insider Buying Galectin Therapeutics Insider Buying Aclaris Therapeutics Insider Buying Lyell Immunopharma Insider Buying SELLAS Life Sciences Group Insider Buying Voyager Therapeutics Insider Buying Journey Medical Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months3 Small Caps Drawing Insider and Institutional Support This page (NASDAQ:CGTX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredMicrosoft's Next Big Bet?Microsoft just broke ground on a revolutionary power system that could deliver virtually limitless, carbon-fre...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cognition Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cognition Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.